<VariationArchive VariationID="2114109" VariationName="NM_000377.3(WAS):c.1040dup (p.Leu347fs)" VariationType="Duplication" Accession="VCV002114109" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2172004" VariationID="2114109">
      <GeneList>
        <Gene Symbol="WAS" FullName="WASP actin nucleation promoting factor" GeneID="7454" HGNC_ID="HGNC:12731" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48676636" stop="48691427" display_start="48676636" display_stop="48691427" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48542185" stop="48549817" display_start="48542185" display_stop="48549817" Strand="+" />
          </Location>
          <OMIM>300392</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000377.3(WAS):c.1040dup (p.Leu347fs)</Name>
      <CanonicalSPDI>NC_000023.11:48688765:TTT:TTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48688765" stop="48688766" display_start="48688765" display_stop="48688766" variantLength="1" positionVCF="48688765" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48547154" stop="48547155" display_start="48547154" display_stop="48547155" variantLength="1" positionVCF="48547154" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>L347fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_125" sequenceAccession="LRG_125">
            <Expression>LRG_125:g.9972dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_125t1" sequenceAccession="LRG_125t1">
            <Expression>LRG_125t1:c.1040dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_125p1" sequenceAccession="LRG_125p1" change="p.Leu347Phefs">
            <Expression>LRG_125p1:p.Leu347Phefs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.48547157dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.48547157dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000377.3" sequenceAccession="NM_000377" sequenceVersion="3" change="c.1040dup" MANESelect="true">
            <Expression>NM_000377.3:c.1040dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000368.1" sequenceAccession="NP_000368" sequenceVersion="1" change="p.Leu347fs">
            <Expression>NP_000368.1:p.Leu347fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.48688768dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.48688768dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007877.1" sequenceAccession="NG_007877" sequenceVersion="1" change="g.9972dup">
            <Expression>NG_007877.1:g.9972dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000377.3(WAS):c.1040dup (p.Leu347fs) AND multiple conditions" Accession="RCV003042620" Version="2">
        <ClassifiedConditionList TraitSetID="11545">
          <ClassifiedCondition DB="MedGen" ID="C1839163">Thrombocytopenia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0043194">Wiskott-Aldrich syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1845987">X-linked severe congenital neutropenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11442475</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12727931</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24210885</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8528198</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11545" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5640" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked severe congenital neutropenia</ElementValue>
                <XRef ID="MONDO:0010294" DB="MONDO" />
                <XRef ID="718882006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SCNX</ElementValue>
                <XRef Type="MIM" ID="300299" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLN</ElementValue>
                <XRef Type="MIM" ID="300299" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3981" />
                <XRef ID="3981" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="86788" DB="Orphanet" />
              <XRef ID="C1845987" DB="MedGen" />
              <XRef ID="MONDO:0010294" DB="MONDO" />
              <XRef Type="MIM" ID="300299" DB="OMIM" />
            </Trait>
            <Trait ID="6264" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">WISKOTT-ALDRICH SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
                <XRef ID="Wiskott+Aldrich+syndrome/7514" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010518" DB="MONDO" />
                <XRef ID="36070007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eczema thrombocytopenia immunodeficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aldrich syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wiskott-aldrich syndrome, somatic</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WAS</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WAS1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD2</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7895" />
                <XRef ID="7895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="906" DB="Orphanet" />
              <XRef ID="C0043194" DB="MedGen" />
              <XRef ID="MONDO:0010518" DB="MONDO" />
              <XRef Type="MIM" ID="301000" DB="OMIM" />
            </Trait>
            <Trait ID="6046" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Thrombocytopenia, X-linked</ElementValue>
                <XRef ID="Thrombocytopenia%2C+x-linked/7084" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">THROMBOCYTOPENIA, X-LINKED, 1</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0016" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked thrombocytopenia with normal platelets</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Thrombocytopenia 1</ElementValue>
                <XRef ID="MONDO:0010743" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS/XLT</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">THC1</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLT</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">THC</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5176" />
                <XRef ID="5176" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="268322" DB="Orphanet" />
              <XRef ID="852" DB="Orphanet" />
              <XRef ID="C1839163" DB="MedGen" />
              <XRef ID="MONDO:0010743" DB="MONDO" />
              <XRef Type="MIM" ID="313900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6020517" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16183401|MedGen:C0043194;C1845987;C1839163" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003332682" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8528198</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11442475</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12727931</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24210885</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu347Phefs*148) in the WAS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 156 amino acid(s) of the WAS protein. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the WAS protein in which other variant(s) (p.Leu425Profs*70) have been determined to be pathogenic (PMID: 8528198, 11442475, 12727931, 24210885). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with WAS-related conditions. This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WAS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.48547154_48547155insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043194" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845987" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1839163" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6020517" TraitType="Disease" MappingType="XRef" MappingValue="C0043194" MappingRef="MedGen">
        <MedGen CUI="C0043194" Name="Wiskott-Aldrich syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6020517" TraitType="Disease" MappingType="XRef" MappingValue="C1839163" MappingRef="MedGen">
        <MedGen CUI="C1839163" Name="Thrombocytopenia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6020517" TraitType="Disease" MappingType="XRef" MappingValue="C1845987" MappingRef="MedGen">
        <MedGen CUI="C1845987" Name="X-linked severe congenital neutropenia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

